enow.com Web Search

  1. Ads

    related to: spiriva reviews for copd

Search results

  1. Results from the WOW.Com Content Network
  2. Tiotropium bromide - Wikipedia

    en.wikipedia.org/wiki/Tiotropium_bromide

    A 2006 review found the increase in bronchospasm was small and did not reach statistical significance. [24] Data regarding some serious side effects is mixed as of 2020. [10] In September 2008 a review found that tiotropium and another member of its class ipratropium may be linked to increased risk of heart attacks, stroke and cardiovascular ...

  3. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14]

  4. Bronchodilator - Wikipedia

    en.wikipedia.org/wiki/Bronchodilator

    Some examples of anticholinergics are tiotropium (Spiriva) and ipratropium bromide. [citation needed] Tiotropium is a long-acting, 24-hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Only available as an inhalant, ipratropium bromide is used in the treatment of asthma and COPD.

  5. 3 Potential Game Changers for COPD - AOL

    www.aol.com/news/2013-07-16-3-potential-game...

    Over 13 million Americans have it. More than 120,000 of them die every year. Chronic obstructive pulmonary disease, or COPD, stands as the third leading cause of death in the U.S. The National ...

  6. A Guide for Living With COPD - AOL

    www.aol.com/guide-living-copd-210000074.html

    Up to 33% of people with COPD have mental-health conditions such as anxiety and depression, according to another review published in 2022.And not only can the condition take a toll on your mood ...

  7. Boehringer to cut out-of-pocket costs for inhalers to $35 - AOL

    www.aol.com/news/boehringer-cut-pocket-costs...

    (Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...

  1. Ads

    related to: spiriva reviews for copd